Search Cancer Clinical Trials

Mass General Brigham Cancer Institute offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
16 results
  • Bladder Cancer

21-348          N/A

Bladder fiducial markers and multiparametric-MRI (mp-MRI) to optimize bladder chemo-radiotherapy

  • Head and Neck Cancer, Gastric (Stomach) Cancer, Prostate Cancer, Endometrial Cancer, Colorectal Cancer, Cervical Cancer, Bladder Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Esophageal Cancer

25-624          Phase I

First-in-Human, Phase 1 Study of ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors

  • Bladder Cancer

25-849          Phase III

NRG-GU015: The Phase III Adaptive Radiation and Chemotherapy for Muscle Invasive Bladder Cancer Trial (ARCHER)

  • Bladder Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Melanoma, Breast Cancer

22-405          Phase II

Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants with Advanced Solid Tumors

  • Bladder Cancer

26-010          Phase II

RANDOMIZED PHASE II TRIAL OF PEMBROLIZUMAB AND RADIATION VS. RADIATION AND CONCURRENT CHEMOTHERAPY FOR HIGH-GRADE T1 BLADDER CANCER (PARRC TRIAL)

  • Bladder Cancer

20-614          Phase I

Sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma progressing on platinum-based chemotherapy and PD1/L1 inhibitors: the Double Antibody Drug conjugate (DAD) Phase I trial

Showing 1 - 10 of 16 results